Yeung R T, Wang C C
Gut. 1974 Nov;15(11):907-12. doi: 10.1136/gut.15.11.907.
Intravenous glucose tolerance, insulin tolerance, tolbutamide, and glucagon tests were carried out in 21 patients with postnecrotic cirrhosis. Based arbitrarily on the bromsulphthalein retention they were divided into group A, nine patients with less impaired liver function, and group B, 12 patients with greater impairment of liver function. Intravenous glucose and insulin tolerances were reduced in both groups. The hypoglycaemic effect of tolbutamide was similar in the controls and in both groups of cirrhotic patients but this was achieved at higher plasma insulin levels in group B indicating resistance of the liver to the effect of endogenous insulin. The blood glucose response to glucagon was markedly impaired in group B patients which is consistent with this hypothesis. In contrast to the insulin response to glucose and tolbutamide, the insulin response to glucagon was reduced in the cirrhotic patients. Fasting human growth hormone and free fatty acid levels were elevated in both groups but they were not considered to be important factors in the production of insulin resistance.
对21例坏死后肝硬化患者进行了静脉葡萄糖耐量、胰岛素耐量、甲苯磺丁脲及胰高血糖素试验。根据溴磺酞钠潴留情况,他们被任意分为A组,9例肝功能损害较轻的患者,和B组,12例肝功能损害较重的患者。两组患者的静脉葡萄糖和胰岛素耐量均降低。甲苯磺丁脲在对照组和两组肝硬化患者中的降血糖作用相似,但B组在较高的血浆胰岛素水平时才达到这一效果,这表明肝脏对内源性胰岛素的作用存在抵抗。B组患者对胰高血糖素的血糖反应明显受损,这与该假设一致。与对葡萄糖和甲苯磺丁脲的胰岛素反应不同,肝硬化患者对胰高血糖素的胰岛素反应降低。两组患者的空腹人生长激素和游离脂肪酸水平均升高,但它们不被认为是产生胰岛素抵抗的重要因素。